Wacker Chemie has announced plans to invest “a double-digit million euro amount” on it the new Biotechnology Centre at its corporate research facility in Munich, which is due to be operational in 2024. CEO Christian Hartel said that building it “will allow us to concentrate and intensify our research activities in the area of biotechnology. The additional capacity we will create here will accelerate the growth of our life-sciences division.”
Dow has announced what it described as “a series of incremental, high-return capacity expansions to support growing demand across key end-markets, all of which value sustainable solutions and continue to grow faster than GDP”. Most relate in full or in part to specialities.
Momentive Performance Materials has outlined what it calls “a series of steps to accelerate its global transition from commodity basics chemicals to speciality silicones”. By the end, it expects to have 300 fewer employees in the Capital Region, where it is also considering investment in R&D facilities.